FBInvestor
Funds / General Catalyst Group Management, LLC
Institutional Fund

General Catalyst Group Management, LLC

Cambridge, MACIK 16379465 filings on record

Portfolio Value
$183.56M
Q1 2026
Holdings
12
Reported positions
New Buys
5
Opened this quarter
QoQ Change
-17.2%
from $221.74M

Portfolio Value Trend

Reported 13F value by quarter

Portfolio value trend — upgrade to see history

Upgrade

Top Allocations

Largest positions by weight

  • Samsara Inc34.5%
  • Arrivent Biopharma Inc18.8%
  • Maze Therapeutics Inc16.8%
  • Maplebear Inc14.5%
  • Gitlab Inc10.9%
  • Eikon Therapeutics Inc1.8%
  • Other2.7%

Portfolio Holdings

12 positions · Q1 2026

#SecuritySharesValue% Port.Δ SharesActivity
1Samsara Inc2.00M$63.38M34.5%0Held
2Arrivent Biopharma Inc1.49M$34.48M18.8%0Held
3Maze Therapeutics Inc1.04M$30.92M16.8%0Held
4Maplebear Inc710.7K$26.62M14.5%0Held
5Gitlab Inc921.4K$19.94M10.9%0Held
6Eikon Therapeutics Inc305.2K$3.23M1.8%+305.2KNew
7Fractyl Health Inc4.88M$2.24M1.2%0Held
8Ethos Technologies Inc74.2K$828.6K0.5%+74.2KNew
9Coupang Inc36.7K$692.5K0.4%+36.7KNew
10Amazon Com Inc2.6K$537.8K0.3%+2.6KNew

2 more holdings on Premium

See this fund's complete portfolio, full position changes, and activity history.

Unlock full portfolio